Maryland joins federal model to improve access to sickle cell treatments
BALTIMORE, MD—The Maryland Department of Health has announced that Maryland Medicaid is joining a new federal initiative to improve access to and lower the cost of life-saving cell and gene therapies for sickle cell disease. By participating in the federal Cell and Gene Therapy (CGT) Access Model, the state will receive enhanced rebates from pharmaceutical manufacturers for high-cost treatments. The […]
